Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daflon (Hesperidin and Diosmin) for Newly Diagnosed COVID-19
NCT04452799Phase 1Unknown
- Sponsor
- Tanta University
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of diosmin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Tanta University. Primary endpoint: RT-PCR negative at 14 days. Status: unknown.
02
Drugs
diosmin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04452799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04452799.